Pharmacoinvasive Therapy With Prourokinase

Clinical trial NCT01642667 · COMPLETED

Trial details

NCT number: NCT01642667
Sponsor: Suzhou Landing Pharmaceuticals
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

ST-segment Elevation Myocardial Infarction (STEMI)

Start date: 2008-11-01
Primary completion: 2009-11-01
Enrollment: 197

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.